Learn how to address PEG immunogenicity, a challenge that affects the safety and efficacy of PEGylated lipid nanoparticles for drug delivery. Discover the latest R&D trends, market data, and...
Learn how to overcome PEG immunogenicity, a challenge that affects the safety and efficacy of PEGylated lipid nanoparticles for drug delivery. This article reviews the current state-of-the-art in...
This peer-reviewed journal publication in Bioconjugate Chemistry shows how PEGylated lipid nanoparticles are used to deliver mRNA vaccines and other drugs, the immunogenicity concerns with vaccines,...
In this edition of the CAS article series, Challenges & Opportunities in Drug Discovery, we talk with Ben Taft, the Senior Director of Chemistry at Via Nova Therapeutics, about structure-activity...
